• DataMeds AI issued 666,667 unregistered common shares valued at $2 million to REBOOT Health AI under an October 13, 2026, license agreement.
• The license covers exclusive US use of REBOOT's platform for the company's direct-to-consumer GLP-1 weight management business.
• Additional shares must cover any shortfall below $2 million in the shares' market value 180 days after the agreement's effective date.
• Any shortfall issuance will use the common stock's 10-day volume-weighted average price as of that date.
• The shares are restricted securities with piggyback registration rights for underwritten public offerings permitting secondary shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DataMeds AI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-047451), on October 16, 2026, and is solely responsible for the information contained therein.